INS and type 2 diabetes mellitus: Various studies have shown that statins may also have modest adverse effects on glucose and insulin metabolism, e.g. increasing the risk of new-onset diabetes, especially in higher doses and with the more potent statins [6–9], but the relationship between statin use and glycaemic control in patients with established T2D is much less clear.